Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
YASMINELLE ORAL CONTRACEPTIVE

Yasminelle, low-dose oral contraceptive approved in the Netherlands

The drug is similar to Schering’s oral contraceptive Yasmin but offers a lower estrogen dose. 

 

BY OUR PHARMA CORRESPONDENT

2 September, 2005: The regulatory authorities in the Netherlands have approved Schering AG's new oral contraceptive Yasminelle. The Netherlands will serve as the Reference Member State for the upcoming Mutual Recognition Procedure to gain European wide marketing approval, an official release from Schering AG said. 

Yasminelle contains 20 micrograms ethinyl estradiol and three milligrams drospirenone in a 21-day active pill intake regimen. The drug is similar to Schering’s oral contraceptive Yasmin but offers a lower estrogen dose with the unique progestin, drospirenone. 

Yasminelle will build upon the success of Yasmin, which is the number one oral contraceptive worldwide. This new low-dose oral contraceptive with the well known pharmacodynamic profile of drospirenone will be offered soon to European women, the release stated. 

Drospirenone exhibits antimineralocorticoid and antiandrogenic properties, unlike any other progestin available in oral contraceptives.

Schering AG is a research-based pharmaceutical company. Its activities are focused on four business areas: Gynecology&Andrology, Oncology, Diagnostic Imaging as well as Specialized Therapeutics for disabling diseases. With in-house R&D and supported by an excellent global network of external partners, Schering AG is securing a promising product pipeline. 

BY OUR PHARMA CORRESPONDENT

BIRTH CONTROL AND SEXUAL HEALTH
Contraceptives, sexual health and pregnancy related news

Once-monthly pill for postmenopausal osteoporosis okayed in Europe 20 September, 2005

US puts off decision on contraceptive pill again

Yasminelle, low-dose oral contraceptive approved in the Netherlands

Morning after pills still not within easy reach in US

Abortion pill to carry 'black box' warning

Contraceptive from Neem, courtesy DRDO

Hormonal contraceptives safe for long-term use: WHO

   Pharma Home

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us